Further analysis of TERMS Phase IIb data shows that 85% of patients treated with Tovaxin responded favorably, 16% showing actual and sustained improvement in disability
http://finance.yahoo.com/news/Opexa-....html?x=0&.v=1
One of our members, Av8rgirl, was in the trials. Here's hoping she might come back and give us an update and let us know what she knows about future trials of Tovaxin!